Cardinal Health SPD and Cencora Specialty Distribution now carry Lasix ONYU, accelerating market penetration through two “Big ...
The Trump administration has officially launched TrumpRx, a program centered on the most-favored nation pricing model. The ...
Cell and gene therapies (CGTs) represent one of the most profound breakthroughs in modern medicine, offering the possibility ...
Community pharmacies are being squeezed out of local markets, creating pharmacy deserts that raise costs, reduce access, and strain the healthcare system. The growth of “pharmacy deserts” represents a ...
In reality, program design covers everything from offer amount and caps to eligibility rules and channel mix, yet many ...
By unifying data, workflows, and decision-making across partners, AI orchestration is enabling healthcare supply chains to ...
In today’s Pharma Pulse, the FTC secures a multi-billion-dollar settlement against the "rebate trap," while Congress provides ...
Within the context of “The Great Repricing,” this distinction matters. The pressure on the commercial channel is not coming ...
Since TrumpRx was announced in 2025, 16 Big Pharma companies have agreed to sell their drugs via the platform, including ...
In today’s Pharma Pulse, AstraZeneca faces a complete response letter for its self-injectable lupus drug, while the EMA gives ...
In today’s Pharma Pulse, the biopharma landscape enters a transformative phase as the US signs landmark PBM reforms into law, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results